Paired tumor sequencing and germline testing in breast cancer management: An experience of a single academic center

BACKGROUND: Genetic testing for cancer predisposition is recommended to women with breast cancer who meet the criteria for such testing. After the FDA approvals of the poly ADP ribose polymerase (PARP) inhibitors, olaparib and talazoparib, for treatment of metastatic breast cancer, carrying germline...

Descripción completa

Detalles Bibliográficos
Autores principales: Elliott, Elizabeth, Speare, Virginia, Coggan, James, Espenschied, Carin, LaDuca, Holly, Yussuf, Amal F., Burgess, Kelly, Gray, Phillip, Cobleigh, Melody, Rao, Ruta, Patel, Jeremy, Kuzel, Timothy, Buckingham, Lela E., Usha, Lydia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941483/
https://www.ncbi.nlm.nih.gov/pubmed/32881420
http://dx.doi.org/10.1002/cnr2.1287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941483/
https://www.ncbi.nlm.nih.gov/pubmed/32881420
http://dx.doi.org/10.1002/cnr2.1287

Ejemplares similares